Endarterectomy vs. Stenting in Asymptomatic Carotid Artery Stenosis

The comparative efficacy and safety of carotid stenting vs. endarterectomy in asymptomatic carotid stenosis patients remains controversial and, what is worse, consensus seems unlikely in the near future. Given the lack of definite evidence, several meta-analyzis and systematic reviews have been produced in an attempt to shed some light on this matter.

Enfermedad carotidea asintomática: ¿Endarterectomía o angioplastia?

This study included all controlled and randomized trials comparing both techniques in asymptomatic patients using a pre-specified protocol.

 

Five controlled studies met the inclusion criteria, adding up more than 3,000 patients.


Read also: New Strategies for the Femoropopliteal Artery”.


The pooled incidence of any periprocedural stroke (RR 1.84; CI 95%, 0.99–3.40), periprocedural nondisabling stroke (RR 1.95; CI 95%, 0.98 – 3.89) and any periprocedural stroke or death (RR 1.72; CI 95%, 0.95 – 3.11) show a tendency against stenting. This tendency was observed in periprocedural events, with no difference in stroke at long term (RR 1.24; CI 95%, 0.76 – 2.03) or with the composite of periprocedural stroke, death, MI or ipsilateral stroke at long term (RR 0.92; IC 95%, 0.70–1.21).

 

Conclusion

The best revascularization technique for patients with asymptomatic carotid stenosis continues to be a matter of debate, despite the higher incidence of periprocedural stroke against stenting seems to tilt the scales in favor of endarterectomy.

 

Editorial Comment

The estimated risk of ipsilateral stroke for asymptomatic patients with a ≥50% stenosis to the internal carotid artery is as low as 0.5 or 1% per year. Hence, in order to show the benefits of revascularization, if any, we would need long term follow up.


Read also: Diabetics’ Silent Ischemia Myth Busted”.


The best medical treatment should be prescribed to these patients, but randomized studies comparing stenting vs. endarterectomy were carried out mostly between 1980 and 2000. Without a shadow of a doubt, current medical treatments are highly superior to any medical treatment two decades old, which is why we should consider a third option to treat these patients, one that the original studies had not considered.

 

At present, there are two randomized studies in progress (SPACE-II y CREST-II) that will provide valuable data on the comparative safety and efficacy of the best medical treatment vs. stenting + the best medical treatment vs. endarterectomy + the best medical treatment.

 

Original title: Carotid Stenting Versus Endarterectomy for Asymptomatic Carotid Artery Stenosis. A Systematic Review and Meta-Analysis.

Reference: Paola Moresoli et al. Stroke. 2017 Aug;48(8):2150-2157.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACURATE Neo2 Underexpansion: Prevalence and Clinical Implications

While transcatheter aortic valve replacement (TAVR) provides durable clinical benefits across a wide range of patients, technical challenges remain that may affect long-term outcomes....

Spontaneous Left Main Dissection: Clinical Characteristics, management and Outcomes

Courtesy of Dr. Juan Manuel Pérez. Spontaneous left main dissection in an uncommon, and potentially life-threatening, cause of acute MI. The aim of this study,...

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...